This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Luster, M. I. Articles by Hayes, H. T. Search for Related Content PubMed PubMed Citation Articles by Luster, M. I. Articles by Hayes, H. T.

Selective Immunosuppression in Mice of Natural Killer Cell Activity by Ochratoxin A

Systemic Toxicology Branch, Toxicology Research and Testing Program, National Institute of Environmental Health Sciences [M. L., D. G., C. J., M. A., K. L., H. H.], and Health Effects Research, Environmental Sciences, Northrop Services, Research Triangle Park, North Carolina 27709 [G. B.]

Ochratoxin A, a naturally occurring mycotoxin, has recently been shown to cause renal and hepatic carcinomas in mice. In the present studies, the effects of ochratoxin A on immune mechanisms associated with tumor resistance were examined in mice using dose levels similar to those that cause neoplasia. Ochratoxin A was shown to specifically inhibit natural killer (NK) cell activity and increase the growth of transplantable tumor cells without altering T-cell- or macrophage-mediated antitumor activity. In contrast, ochratoxin B, a much less toxic ochratoxin, did not influence immune function. Polyinosinic:polycytidylic induced interferon was markedly reduced in mice following exposure to ochratoxin A although total serum protein levels were slightly increased. Injection of polyinosinic:polycytidylic enhanced NK activity in the presence of ochratoxin A, although the level of enhancement was slightly lower than that produced by the agent in the absence of ochratoxin A. Thus, ochratoxin appears to suppress NK cell activity by inhibiting production of basal interferon. Additionally, these findings suggest a possible role for altered NK cell function in the development of mycotoxin-induced carcinogenesis.

¹ To whom requests for reprints should be addressed.

² Present address: P.O. Box 3493, MGMC, Andrews AFB, MD 20331.

Received 11/19/86. Revised 2/ 3/87. Accepted 2/ 5/87.

This article has been cited by other articles:

				L Alvarez-Erviti, C Leache, E Gonzalez-Penas, and A L. de Cerain Alterations induced in vitro by ochratoxin a in rat lymphoid cells Human and Experimental Toxicology, September 1, 2005; 24(9): 459 - 466. [Abstract] [PDF]

				C. L. Schwab, R. Fan, Q. Zheng, L. P. Myers, P. Hebert, and S. B. Pruett Modeling and Predicting Stress-Induced Immunosuppression in Mice Using Blood Parameters Toxicol. Sci., January 1, 2005; 83(1): 101 - 113. [Abstract] [Full Text] [PDF]

				H. Assaf, H. Azouri, and M. Pallardy Ochratoxin A Induces Apoptosis in Human Lymphocytes through Down Regulation of Bcl-xL Toxicol. Sci., June 1, 2004; 79(2): 335 - 344. [Abstract] [Full Text] [PDF]